Avanos Medical, Inc. - stock earnings
AVNS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | 0.19 / 0.22 | - | 166.1 million / 166.2 million | - |
AVNS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 2.5 million USD | 166.1 million USD |
| 2023Q4 | 10.5 million USD | 173.3 million USD |
| 2023Q3 | -3.7 million USD | 171.3 million USD |
| 2023Q2 | -68.1 million USD | 169.4 million USD |
| 2023Q1 | -500000 USD | 191.7 million USD |
| 2022Q4 | 16.9 million USD | 217.5 million USD |
| 2022Q3 | 15.7 million USD | 202.1 million USD |
| 2022Q2 | 11.4 million USD | 203.0 million USD |
| 2022Q1 | 5.8 million USD | 197.4 million USD |
| 2021Q4 | 10.0 million USD | 193.4 million USD |
| 2021Q3 | -35.1 million USD | 184.1 million USD |
| 2021Q2 | 37.9 million USD | 186.4 million USD |
| 2021Q1 | -7.6 million USD | 180.7 million USD |
| 2020Q4 | -47.2 million USD | 185.0 million USD |
| 2020Q3 | 19.3 million USD | 185.7 million USD |
| 2020Q2 | -3.0 million USD | 163.7 million USD |
| 2020Q1 | 3.7 million USD | 180.4 million USD |
| 2019Q4 | -6.1 million USD | 189.8 million USD |
| 2019Q3 | -11.5 million USD | 171.4 million USD |
| 2019Q2 | -8.0 million USD | 172.2 million USD |
| 2019Q1 | -20.3 million USD | 164.2 million USD |
| 2018Q4 | -2.2 million USD | 169.9 million USD |
| 2018Q3 | 4.2 million USD | 165.1 million USD |
| 2018Q2 | 35.3 million USD | 160.9 million USD |
| 2018Q1 | 20.2 million USD | 156.4 million USD |
| 2017Q4 | 32.8 million USD | -584.6 million USD |
| 2017Q3 | 16.6 million USD | 401.4 million USD |
| 2017Q2 | 17.1 million USD | 399.2 million USD |
| 2017Q1 | 12.8 million USD | 395.6 million USD |
| 2016Q4 | 10.0 million USD | 410.0 million USD |
| 2016Q3 | 9.1 million USD | 397.5 million USD |
| 2016Q2 | 6.5 million USD | 400.0 million USD |
| 2016Q1 | 14.2 million USD | 384.8 million USD |
| 2015Q4 | 14.5 million USD | 401.4 million USD |
| 2015Q3 | -470.5 million USD | 389.5 million USD |
| 2015Q2 | 8.0 million USD | 389.3 million USD |
| 2015Q1 | 21.7 million USD | 394.2 million USD |
| 2014Q4 | -2.4 million USD | 439.4 million USD |
| 2014Q3 | -7.4 million USD | 408.5 million USD |
| 2014Q2 | -4.5 million USD | 413.5 million USD |
| 2014Q1 | 41.4 million USD | 410.7 million USD |
| 2013Q4 | 39.8 million USD | 431.3 million USD |
| 2013Q3 | 47.9 million USD | 419.5 million USD |
| 2013Q2 | 38.6 million USD | 415.9 million USD |
| 2013Q1 | 28.3 million USD | 410.8 million USD |
| 2012Q4 | 152.6 million USD | 1.7 billion USD |
AVNS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.8 million USD | 673.3 million USD |
| 2022 | 50.5 million USD | 820.0 million USD |
| 2021 | 6.3 million USD | 744.6 million USD |
| 2020 | -27.2 million USD | 714.8 million USD |
| 2019 | -45.9 million USD | 697.6 million USD |
| 2018 | 57.5 million USD | 652.3 million USD |
| 2017 | 79.3 million USD | 611.6 million USD |
| 2016 | 39.8 million USD | 1.6 billion USD |
| 2015 | -426.3 million USD | 1.6 billion USD |
| 2014 | 27.1 million USD | 1.7 billion USD |
| 2013 | 154.6 million USD | 1.7 billion USD |
| 2012 | 152.6 million USD | 1.7 billion USD |
| 2011 | 142.4 million USD | 1.7 billion USD |
AVNS
Price: $19.64
52 week price:
Earnings Per Share: -0.21 USD
P/E Ratio: 52.57
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 284800
Market Capitalization: 903.4 million